Salarius Pharmaceuticals
(NASDAQ) SLRX
Salarius Pharmaceuticals Financials at a Glance
Market Cap
$3.09M
Revenue (TTM)
$0.00
Net Income (TTM)
$12.52M
EPS (TTM)
$-304.79
P/E Ratio
-0.02
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$5.80
Volume
14,816.158
Open
$6.27
Price
$5.80
Volume
14,816.158
Open
$6.27
Previous Close
$5.80
Daily Range
$5.60 - $6.48
52-Week Range
$5.60 - $415.80
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$5.80
Volume
14,816.158
Open
$6.27
Previous Close
$5.80
Daily Range
$5.60 - $6.48
52-Week Range
$5.60 - $415.80
SLRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Salarius Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
11
CEO
Frederick E. Pierce, II
Website
decoytx.comHeadquarters
Houston, TX 77021, US
SLRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-338%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-50.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.09M
Shares Outstanding
532.00K
Volume
14.82K
Short Interest
0.00%
Avg. Volume
187.33K
Financials (TTM)
Gross Profit
$8.52M
Operating Income
$12.61M
EBITDA
$12.61M
Operating Cash Flow
$4.83M
Capital Expenditure
$0.00
Free Cash Flow
$4.83M
Cash & ST Invst.
$10.71M
Total Debt
$0.00
Salarius Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$8.52M
N/A
Gross Margin
0.00%
N/A
Market Cap
$3.09M
N/A
Market Cap/Employee
$1.54M
N/A
Employees
2
N/A
Net Income
$8.98M
-513.3%
EBITDA
$9.07M
-509.9%
Quarterly Fundamentals
Net Cash
$10.71M
+384.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-1.13%
N/A
Return on Invested Capital
-2.14%
N/A
Free Cash Flow
$1.14M
-53.1%
Operating Cash Flow
$1.14M
-53.1%